The Hailie® solution has been used in over 60 clinical programs and its performance has been reported in at least 76 independent peer-reviewed studies. It has been shown to improve inhaler medication adherence and associated health outcomes for patients with asthma.
Hailie® technology has been independently shown to:
- Increase adherence to preventer/controller inhaler medication by 180% in children and 59% in adults.
- Reduce severe exacerbations in adults by 60%.
- Reduce hospital admissions in children by 80%, and
- Reduce reliever/rescue inhaler medication use in children by 45%
Click here to view our clinical publications.